Literature DB >> 1551496

Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma.

E T Lee1, V S Lee, M Lu, D Russell.   

Abstract

To determine the incidence of and risk factors for the development of proliferative diabetic retinopathy (PDR) in Oklahoma Indians, we performed a cohort follow-up study of 927 Indians who underwent detailed eye examinations between 1972 and 1980. The mean age of participants was 52 yr with a duration of diabetes of 6.9 yr at baseline. At follow-up, 513 (55.3%) were alive, 407 (43.9%) were deceased, and 7 (0.8%) could not be traced. After a mean follow-up time of 12.7 yr, the overall incidence of PDR among those who survived and who underwent follow-up ophthalmic examinations (354 participants) was 18.6%; 45% of those with background retinopathy at baseline developed PDR. Significant independent predictors of PDR, determined by multivariate analysis, were fasting plasma glucose level, duration of diabetes, plasma cholesterol, systolic blood pressure, and therapeutic regimen. A fasting plasma glucose level greater than or equal to 11.1 mM (200 mg/dl) increased the risk of retinopathy to 3.6 times that for a level less than 7.8 mM (140 mg/dl); 74% of those who had background retinopathy and a baseline fasting glucose greater than or equal to 11.1 mM (200 mg/dl) developed PDR. Over half of all participants with plasma cholesterol levels greater than or equal to 7.8 mM (300 mg/dl) developed PDR in the follow-up interval. Elevated systolic blood pressure was a particularly significant risk factor for those with a long duration of diabetes. Proliferative retinopathy poses a serious health threat to Oklahoma Indians and represents a cause of visual impairment that may be preventable by early diagnosis of PDR and intervention with photocoagulation therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551496     DOI: 10.2337/diab.41.3.359

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

Review 1.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

2.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2008-11       Impact factor: 12.079

3.  Risk factors for proliferative diabetic retinopathy in a Latino American population.

Authors:  Muneeswar G Nittala; Pearse A Keane; Kang Zhang; Srinivas R Sadda
Journal:  Retina       Date:  2014-08       Impact factor: 4.256

4.  Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.

Authors:  Sven-Erik Bursell; Stephanie J Fonda; Drew G Lewis; Mark B Horton
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

5.  Is there a relationship between body mass index and diabetic retinopathy in type II diabetic patients? A cross sectional study.

Authors:  Zahra Sarrafan-Chaharsoughi; Masoud Reza Manaviat; Nasim Namiranian; Pouria Yazdian-Anari; Masoud Rahmanian
Journal:  J Diabetes Metab Disord       Date:  2018-04-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.